展示文件99.1

^{®此款超便攜式投影儀使用了最新的 Android TV 界面，而且遙控器還內置了 Google AssistantTM 功能，用户可以非常方便地使用它。}

關於Microbot Medical

納斯達克公司Microbot Medical Inc.（NASDAQ：MBOT）是一家臨牀階段的醫療器械公司，專注於轉化微型機器人技術，旨在通過人體內的自然和人工腔道改善患者的臨牀結果並提高機會。

“自由”先令^®一種內血管機器人手術系統，旨在通過消除大型、笨重和昂貴的資本設備，同時減少輻射和醫生負擔，來改善內血管手術中機器人的使用方式。^®Endovascular Robotic Surgical System的遠程操作有可能成為第一個民主化內血管介入手術的系統。

有關Microbot Medical的更多信息可在http://www.microbotmedical.com上獲得。

免責聲明

Statements to future financial and/or operating results, future growth in research, technology, clinical development, and potential opportunities for Microbot Medical Inc. and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Any statements that are not historical fact (including, but not limited to statements that contain words such as “will,” “believes,” “plans,” “anticipates,” “expects” and “estimates”) should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, market conditions, risks inherent in the development and/or commercialization of the LIBERTY.^® Endovascular Robotic Surgical System的研究結果評估LIBERTY的結果以及^®Endovascular Robotic Surgical System的不確定性在臨牀前和臨牀試驗或審查途徑和審批方面，包括公司的關鍵性人類試驗是否成功，任何未能招募醫生和臨牀醫生作為指導性調查的首席研究員可能對這些研究產生負面影響或延遲該類研究，因以色列和巴勒斯坦和其他鄰國之間的新的和持續的敵對行動所引起的幹擾，COVID-19大流行的任何懸而未決情況，未來資本的需求和能力以及知識產權的維護，都存在風險和不確定性。

投資者聯繫方式：

米哈爾·埃夫拉蒂

IR@microbotmedical.com